Clinical Trial Update: Expression of TIM-3 on Lymphocytes in Sepsis

View source ↗

Summary

This document provides a clinical trial update investigating TIM-3 expression on lymphocytes in patients with sepsis. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Changhai Hospital | Conditions: Sepsis, Immunosuppression | Status: UNKNOWN